News

This is to alert you on the fact that the WHO New Tuberculosis Vaccines Preferred Product Characteristics document is available on-line for public review through the following link:

The Joint Programming Initiative on Antimicrobial Resistance (JPI AMR) published a call that offers opportunities for our partners: “Innovations against antibiotic-resistant bacteria: new [...]

Oxford response to recent BMJ article. Read the article.  

The Stop TB Partnership Working Group on New TB Vaccines has launched a new website offering a broad range of resources on TB vaccine development. The website provides essential background [...]

This week, as health ministers, diplomats and other representatives meet to discuss tuberculosis (TB) at the World Health Organization (WHO) Ministerial Conference in Moscow, millions of people [...]